Ingrid Egeland Christensen

6PUBLICATIONS
10CO-AUTHORS
AutoimmunityInnate immunityImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 27, 2025
Comment on: Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls: Reply.

Ingrid Egeland Christensen, Siri Lillegraven, Till Uhlig

|Mar 10, 2025
Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls.

Ingrid Egeland Christensen, Siri Lillegraven, Joseph Sexton

|Apr 10, 2024
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.

Hilde S Ørbo, Kristin H Bjørlykke, Joseph Sexton

|Nov 03, 2022
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy.

Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter

|Oct 05, 2022
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study.

Ingrid Egeland Christensen, Ingrid Jyssum, Anne Therese Tveter

|Oct 09, 2021
Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study.

Ingrid Egeland Christensen, Siri Lillegraven, Pawel Mielnik

Pageof 1

Frequent Collaborators

5 joint publications

Sella Aarrestad Provan

3 joint publications

Till Uhlig

2 joint publications

Kristin Hammersbøen Bjørlykke

2 joint publications

Ingrid Jyssum